Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 12:31 PM ET

Date/Time Source News Release
04/30/2025 08:30 AM EDT GlobeNewswire Oncocyte Provides Positive Update on Clinical Trial Progress
04/29/2025 08:30 AM EDT GlobeNewswire Oncocyte's Proprietary Assay Demonstrates Long-Term Clinical Validity
04/02/2025 08:45 AM EDT GlobeNewswire Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
03/24/2025 04:05 PM EDT GlobeNewswire Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
03/18/2025 04:05 PM EDT GlobeNewswire Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
02/11/2025 08:30 AM EST GlobeNewswire Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
02/10/2025 08:30 AM EST GlobeNewswire Oncocyte Prices $29.1 Million Equity Offering
01/08/2025 08:30 AM EST GlobeNewswire Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
01/06/2025 04:05 PM EST GlobeNewswire Oncocyte Expands Market Opportunity for VitaGraft(TM) Kidney
12/09/2024 04:05 PM EST GlobeNewswire Oncocyte to Participate in "J.P. Morgan Week" and Host Investor Meetings
Page

Additional News

As of April 30, 2025 • 12:31 PM ET

Date/Time Source News Release
04/29/2025 12:01 PM EDT PRISM News Oncocyte's Transplant Rejection Test Shows Long-Term Utility in Kidney Recipients, According to New Study
04/24/2025 06:31 AM EDT Zacks New Strong Buy Stocks for April 24th
04/07/2025 12:00 PM EDT Zacks OncoCyte (OCX) Upgraded to Buy: What Does It Mean for the Stock?
03/28/2025 11:26 AM EDT SeekingAlpha OncoCyte a new buy at Lake Street on transplant rejection testing
03/24/2025 06:54 PM EDT SeekingAlpha Oncocyte targets $20M in recurring revenue from 20 transplant centers by 2025
03/24/2025 06:53 PM EDT SeekingAlpha OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript
03/24/2025 04:07 PM EDT SeekingAlpha OncoCyte GAAP EPS of -$1.93, revenue of $1.49M
03/24/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
03/24/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, March 24th, 2025
03/24/2025 05:31 AM EDT US Earnings Reports Expected earnings - Oncocyte Corporation
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.